|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nickel carbonyl | CAS 13463-39-3 | ||
| Ni(CO)4 | RTECS QR6300000 | ||
|
Synonyms & Trade Names Nickel tetracarbonyl, Tetracarbonyl nickel |
DOT ID & Guide 1259 131 |
||
|
Exposure Limits |
NIOSH REL: Ca TWA 0.001 ppm (0.007 mg/m3) See Appendix A | ||
| OSHA PEL: TWA 0.001 ppm (0.007 mg/m3) | |||
| IDLH Ca [2 ppm] | Conversion 1 ppm = 6.98 mg/m3 | ||
|
Physical Description Colorless to yellow liquid with a musty odor. [Note: A gas above 110°F.] |
|||
|
MW: 170.7 |
BP: 110°F |
FRZ: -13°F |
Sol: 0.05% |
|
VP: 315 mmHg |
IP: 8.28 eV |
|
Sp.Gr(63°F): 1.32 |
|
Fl.P: <-4°F |
UEL: ? |
LEL: 2% |
|
| Class IB Flammable Liquid: Fl.P. below 73�F and BP at or above 100�F. | |||
|
Incompatibilities & Reactivities Nitric acid, bromine, chlorine & other oxidizers; flammable materials |
|||
|
Measurement Methods NIOSH 6007 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet (flammable) Change: No recommendation Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted canister providing protection against the compound of concern/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, ingestion, skin absorption, skin and/or eye contact | |
| Symptoms Headache, dizziness; nausea, vomiting, epigastric pain; substernal pain; cough, hyperpnea; cyanosis; lassitude (weakness, exhaustion); leukocytosis (increased blood leukocytes), pneumonitis; delirium, convulsions; [potential occupational carcinogen]; in animals: reproductive, teratogenic effects | |
|
Target Organs
Lungs, paranasal sinus, central nervous system, reproductive system Cancer Site [lung & nasal cancer] |
|
| See also: INTRODUCTION |